Life sciences researchers, thought leaders and industry colleagues gathered in Singapore in early September to discuss the status of pharmacoeconomics and outcomes research in the Asia-Pacific region. The 7th ISPOR Asia-Pacific conference presented an opportunity to concentrate on the issues particular to this unique and diverse part of the world in an effort to achieve improved health care decisions, greater equity, and sustainable costs.
Both the opportunities and challenges are bountiful in AsiaPac health care. As Adele Weston, executive vice president/senior scientist, recently noted, vast differences in historical, socio-economic, cultural and political backgrounds have resulted in diverse health systems with differing needs and highly variable health outcomes across populations. There is no “one size fits all” solution here. At the same time, growth and development across AsiaPac is coinciding with the advent of new health technologies, data availability and a growing consciousness of improving and increasing access to health care.
Last month, Asia Pacific Leader and Senior Director Alasdair Godfrey highlighted some of the pressing concerns for health economics outcomes research (HEOR) and health technology assessment (HTA) in the Asia-Pacific region. “As health care and medical technology continue to evolve rapidly, the advent of innovative technology requires equally innovative ways to assess the efficacy and value,” he remarked. “Novel ways of assessing new technologies need to be devised and implemented, especially when it comes to fair and sustainable pricing strategies as well as access to and application of real-world data.” The ISPOR conference is critical in helping keep pace with this rapid evolution and ensuring pioneering health care research continues to be supported.
Our team is passionate about the opportunity to contribute expertise and help make an impact. We were pleased to present an educational symposium and four posters for this meeting, along with connecting with numerous attendees at our booth.
Thank you, ISPOR, for a productive meeting and the chance to put our collective expertise together toward the goal of a healthier future in the Asia-Pacific region. We consider the conference a learning opportunity to inform our efforts and apply that knowledge to better translate research into meaningful change.
About the Author:
President, Research Consulting and PROs
Optum Life Sciences